Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Intervention With Leukotriene Receptor Antagonists in Patients With Grass Pollinosis: Effects on Clinical Symptoms and Allergic Inflammation

NCT05040828 is registered in ClinicalTrials.gov with Beijing Tongren Hospital as lead sponsor.

NCT NCT05040828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05040828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Intervention With Leukotriene Receptor Antagonists in Patients With Grass Pollinosis: Effects on Clinical Symptoms and Allergic Inflammation
Lead sponsor
Beijing Tongren Hospital
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2020
Completion date
November 10, 2020
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis due to weed pollen, montelukast